Literature DB >> 31821546

Treatments for primary delusional infestation.

Iyas Assalman1, Alia Ahmed2, Randa Alhajjar3, Anthony P Bewley4, Ruth Taylor5.   

Abstract

BACKGROUND: Primary delusional infestation (DI) is a primary psychiatric disorder characterised by delusions and abnormal tactile sensations. The pathophysiology is undecided and treatment includes both pharmacological and non-pharmacological options. There is currently no Cochrane Review of the treatments used. Primary DI is a diagnosis often encountered by both dermatologists and psychiatrists, with a large associated disease burden.
OBJECTIVES: To evaluate the effectiveness of different treatments in primary delusional infestation (DI). SEARCH
METHODS: On 24 December 2014 and 19 March 2019, we searched the Cochrane Schizophrenia Group's Study-Based Register of Trials including registries of clinical trials. SELECTION CRITERIA: Randomised controlled trials involving the treatment of adults with primary DI. DATA COLLECTION AND ANALYSIS: Two review authors independently screened and assessed studies for inclusion using pre-specified inclusion criteria. MAIN
RESULTS: We did not identify any studies for inclusion. AUTHORS'
CONCLUSIONS: Currently there is no evidence from RCTs available to compare treatment of primary DI with placebo. We cannot, therefore, make any conclusions regarding the effects of treatments (pharmacological or non-pharmacological) for primary DI. This lack of evidence for treatment of primary DI has implications for research and practice. Robust randomised trials are indicated.
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31821546      PMCID: PMC6903768          DOI: 10.1002/14651858.CD011326.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  39 in total

1.  Clinical implications of Brief Psychiatric Rating Scale scores.

Authors:  Stefan Leucht; John M Kane; Werner Kissling; Johannes Hamann; Eva Etschel; Rolf Engel
Journal:  Br J Psychiatry       Date:  2005-10       Impact factor: 9.319

2.  Imputing missing standard deviations in meta-analyses can provide accurate results.

Authors:  Toshi A Furukawa; Corrado Barbui; Andrea Cipriani; Paolo Brambilla; Norio Watanabe
Journal:  J Clin Epidemiol       Date:  2006-01       Impact factor: 6.437

3.  Detecting skewness from summary information.

Authors:  D G Altman; J M Bland
Journal:  BMJ       Date:  1996-11-09

Review 4.  A population-based study of the incidence of delusional infestation in Olmsted County, Minnesota, 1976-2010.

Authors:  C H Bailey; L K Andersen; G C Lowe; M R Pittelkow; J M Bostwick; M D P Davis
Journal:  Br J Dermatol       Date:  2014-05       Impact factor: 9.302

5.  Delusions of infestation: treatment by depot injections of neuroleptics.

Authors:  A Frithz
Journal:  Clin Exp Dermatol       Date:  1979-12       Impact factor: 3.470

6.  Patients with delusional infestation (delusional parasitosis) often require prolonged treatment as recurrence of symptoms after cessation of treatment is common: an observational study.

Authors:  S Wong; A Bewley
Journal:  Br J Dermatol       Date:  2011-10       Impact factor: 9.302

Review 7.  An approach to the treatment of psychogenic parasitosis.

Authors:  K Zanol; J Slaughter; R Hall
Journal:  Int J Dermatol       Date:  1998-01       Impact factor: 2.736

Review 8.  Antipsychotic treatment of primary delusional parasitosis: systematic review.

Authors:  Peter Lepping; Ian Russell; Roland W Freudenmann
Journal:  Br J Psychiatry       Date:  2007-09       Impact factor: 9.319

9.  The unit of analysis error in studies about physicians' patient care behavior.

Authors:  G W Divine; J T Brown; L M Frazier
Journal:  J Gen Intern Med       Date:  1992 Nov-Dec       Impact factor: 5.128

10.  Delusions of parasitosis. A psychiatric disorder to be treated by dermatologists? An analysis of 33 patients.

Authors:  S F Zomer; R F De Wit; J E Van Bronswijk; G Nabarro; W A Van Vloten
Journal:  Br J Dermatol       Date:  1998-06       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.